Istituto Comprensivo Primo, 98057 Milazzo, Italy.
Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.
Int J Mol Sci. 2022 Feb 16;23(4):2171. doi: 10.3390/ijms23042171.
Several diseases (such as diabetes, cancer, and neurodegenerative disorders) affect the morpho-functional aspects of red blood cells, sometimes altering their normal metabolism. In this review, the hematological changes are evaluated, with particular focus on the morphology and metabolic aspects of erythrocytes. Changes in the functionality of such cells may, in fact, help provide important information about disease severity and progression. The viral infection causes significant damage to the blood cells that are altered in size, rigidity, and distribution width. Lower levels of hemoglobin and anemia have been reported in several studies, and an alteration in the concentration of antioxidant enzymes has been shown to promote a dangerous state of oxidative stress in red blood cells. Patients with severe COVID-19 showed an increase in hematological changes, indicating a progressive worsening as COVID-19 severity progressed. Therefore, monitored hematological alterations in patients with COVID-19 may play an important role in the management of the disease and prevent the risk of a severe course of the disease. Finally, monitored changes in erythrocytes and blood, in general, may be one of the causes of the condition known as Long COVID.
几种疾病(如糖尿病、癌症和神经退行性疾病)会影响红细胞的形态和功能,有时会改变其正常的新陈代谢。在这篇综述中,我们评估了血液学变化,特别关注红细胞的形态和代谢方面。这些细胞功能的变化实际上可能有助于提供有关疾病严重程度和进展的重要信息。病毒感染会对血细胞造成严重损伤,导致其大小、刚性和分布宽度发生改变。几项研究报告指出,血红蛋白水平降低和贫血,以及抗氧化酶浓度的改变,会促进红细胞中危险的氧化应激状态。严重 COVID-19 患者表现出血液学变化增加,表明随着 COVID-19 严重程度的进展,病情逐渐恶化。因此,监测 COVID-19 患者的血液学变化可能在疾病的管理中发挥重要作用,防止疾病严重发作的风险。最后,监测红细胞和血液的变化可能是被称为“长新冠”的病症的原因之一。